Cargando…
Slowing the Progression of Diabetic Kidney Disease
Diabetes is the most frequent cause of kidney disease that progresses to end-stage renal disease worldwide, and diabetic kidney disease is significantly related to unfavorable cardiovascular outcomes. Since the 1990s, specific therapies have emerged and been approved to slow the progression of diabe...
Autores principales: | Blazek, Olivia, Bakris, George L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417620/ https://www.ncbi.nlm.nih.gov/pubmed/37566054 http://dx.doi.org/10.3390/cells12151975 |
Ejemplares similares
-
Modifying chronic kidney disease progression with the mineralocorticoid receptor antagonist finerenone in patients with type 2 diabetes
por: DeFronzo, Ralph A., et al.
Publicado: (2022) -
SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes
por: Wheeler, David C., et al.
Publicado: (2020) -
Hypertension Management in Diabetic Kidney Disease
por: Patney, Vikram, et al.
Publicado: (2015) -
Diabetic Kidney Disease: A Determinant of Cardiovascular Risk in Type 1 Diabetes
por: de Boer, Ian H., et al.
Publicado: (2018) -
Therapeutic strategies to slow chronic kidney disease progression
por: Wühl, Elke, et al.
Publicado: (2008)